Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeff Smith

Showing results (21-30 of 86) with videos related to

Pageof 9
Sort By:
Clinical Breast Cancer|March 20, 2016
Extracapsular Extension in the Sentinel Lymph Node: Guidelines for TherapySantosh Swaminathan, Michael Reintgen, Lauren Kerivan, et al.
IEEE Open Journal of Engineering in Medicine and Biology|April 11, 2022
Prediction for the Risk of Multiple Chronic Conditions Among Working Population in the United States With Machine Learning ModelsJingmei Yang, Xinglong Ju, Feng Liu, et al.
Clinical Pharmacokinetics|July 3, 2021
Correction to: Population Cellular Kinetics of Lisocabtagene Maraleucel, an Autologous CD19-Directed Chimeric Antigen Receptor T-Cell Product, in Patients with Relapsed/Refractory Large B-Cell LymphomaKen Ogasawara, Michael Dodds, Timothy Mack, et al.
Plos One|August 26, 2020
The efficacy of a compounded micronutrient supplement on the incidence, duration, and severity of the common cold: A pilot randomized, double-blinded, placebo-controlled trialJames G Lenhart, Phuong T Vu, Kale Quackenbush, et al.
Endocrinology, Diabetes & Metabolism|April 15, 2021
Tolerability of eptinezumab in overweight, obese or type 1 diabetes patientsBrian Baker, Barbara Schaeffler, Joe Hirman, et al.
Clinical Neuropathology|May 19, 2016
Emperipolesis in eosinophilic granuloma of the skullIndrani Karpha, Emanuel Chavredakis, Kumar Das, et al.
Clinical Pharmacokinetics|June 14, 2021
Population Cellular Kinetics of Lisocabtagene Maraleucel, an Autologous CD19-Directed Chimeric Antigen Receptor T-Cell Product, in Patients with Relapsed/Refractory Large B-Cell LymphomaKen Ogasawara, Michael Dodds, Timothy Mack, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society|January 7, 2005
Structure-activity studies on prolactin-releasing peptide (PrRP). Analogues of PrRP-(19-31)-peptideRobert G Boyle, Robert Downham, Tanmoy Ganguly, et al.
The Clinical Teacher|January 24, 2020
Postgraduate Diploma in Emergency Medicine in IndiaKevin Davey, Narendra Nath Jena, Janice Blanchard, et al.
Headache|November 9, 2020
Eptinezumab Demonstrated Efficacy in Sustained Prevention of Episodic and Chronic Migraine Beginning on Day 1 After DosingDavid W Dodick, Christopher Gottschalk, Roger Cady, et al.
Pageof 9

Showing results (21-30 of 86) with videos related to

Sort By:
Pageof 9
Clinical Breast Cancer|March 20, 2016
Extracapsular Extension in the Sentinel Lymph Node: Guidelines for TherapySantosh Swaminathan, Michael Reintgen, Lauren Kerivan, et al.
IEEE Open Journal of Engineering in Medicine and Biology|April 11, 2022
Prediction for the Risk of Multiple Chronic Conditions Among Working Population in the United States With Machine Learning ModelsJingmei Yang, Xinglong Ju, Feng Liu, et al.
Clinical Pharmacokinetics|July 3, 2021
Correction to: Population Cellular Kinetics of Lisocabtagene Maraleucel, an Autologous CD19-Directed Chimeric Antigen Receptor T-Cell Product, in Patients with Relapsed/Refractory Large B-Cell LymphomaKen Ogasawara, Michael Dodds, Timothy Mack, et al.
Plos One|August 26, 2020
The efficacy of a compounded micronutrient supplement on the incidence, duration, and severity of the common cold: A pilot randomized, double-blinded, placebo-controlled trialJames G Lenhart, Phuong T Vu, Kale Quackenbush, et al.
Endocrinology, Diabetes & Metabolism|April 15, 2021
Tolerability of eptinezumab in overweight, obese or type 1 diabetes patientsBrian Baker, Barbara Schaeffler, Joe Hirman, et al.
Clinical Neuropathology|May 19, 2016
Emperipolesis in eosinophilic granuloma of the skullIndrani Karpha, Emanuel Chavredakis, Kumar Das, et al.
Clinical Pharmacokinetics|June 14, 2021
Population Cellular Kinetics of Lisocabtagene Maraleucel, an Autologous CD19-Directed Chimeric Antigen Receptor T-Cell Product, in Patients with Relapsed/Refractory Large B-Cell LymphomaKen Ogasawara, Michael Dodds, Timothy Mack, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society|January 7, 2005
Structure-activity studies on prolactin-releasing peptide (PrRP). Analogues of PrRP-(19-31)-peptideRobert G Boyle, Robert Downham, Tanmoy Ganguly, et al.
The Clinical Teacher|January 24, 2020
Postgraduate Diploma in Emergency Medicine in IndiaKevin Davey, Narendra Nath Jena, Janice Blanchard, et al.
Headache|November 9, 2020
Eptinezumab Demonstrated Efficacy in Sustained Prevention of Episodic and Chronic Migraine Beginning on Day 1 After DosingDavid W Dodick, Christopher Gottschalk, Roger Cady, et al.
Pageof 9